The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Genome-wide analysis of disease progression in age-related macular degeneration
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Human genetics point to S2R as a promising therapeutic target for dry AMD, as several large-scale independent genome-wide association studies indicate that a single nucleotide polymorphism in the TMEM-VTN locus confers decreased risk for dry AMD.
“First, human genetics point to S2R as a promising therapeutic target, as indicated via several large-scale, independent genome-wide association studies. These studies indicate that a single nucleotide polymorphism in the TMEM-VTN locus confers decreased risk for dry AMD [168,169].”
From Sigma-2 Receptors—From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases (2023) · cites this paper as [169]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maller, J., George, S., Purcell, S., Fagerness, J., Altshuler, D., Daly, M. J., & Seddon, J. M. (2006) · Nature Genetics · doi:10.1038/ng1873 · Cited by 599
Susceptibility genes for age-related maculopathy on chromosome 10q26
Jakobsdottir, J., Conley, Y. P., Weeks, D. E., Mah, T. S., Ferrell, R. E., & Gorin, M. B. (2005) · The American Journal of Human Genetics · doi:10.1086/444437 · Cited by 470
Self-citationLi, M., Atmaca-Sonmez, P., Othman, M., Branham, K. E. H., Khanna, R., Wade, M. S., Li, Y., Liang, L., Zareparsi, S., Swaroop, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1871 · Cited by 354
Self-citationAssociation of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration
Seddon, J. M., Francis, P. J., George, S., Schultz, D. W., Rosner, B., & Klein, M. L. (2007) · JAMA · doi:10.1001/jama.297.16.1793 · Cited by 330
Self-citation
Flagged first, then by citations
Research works printed but not linked: 20
- Age-Related Eye Disease Study Research, 1999, The age-related eye disease study (AREDS): design implications. AREDS report no. 1, Control. Clin. Trials, 20, 573
- Fritsche, 2013, Seven new loci associated with age-related macular degeneration, Nat. Genet, 45, 433
- Fritsche, 2016, A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants, Nat. Genet, 48, 134
- Chen, 2010, Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration, Proc. Natl. Aacd Sci. U.S.A, 107, 7401
- Rivera, 2005, Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk, Hum. Mol. Genet, 14, 3227
- Seddon, 2011, Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors, Ophthalmology, 118, 2203
- Seddon, 2009, Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables, Invest. Ophthalmol. Vis. Sci, 50, 2044
- Farwick, 2010, Susceptibility genes and progression in age-related maculopathy: a study of single eyes, Invest. Ophthalmol. Vis. Sci, 51, 731
- Klein, 2011, Risk assessment model for development of advanced age-related macular degeneration, Arch. Ophthalmol, 129, 1543
- Ding, 2017, Bivariate analysis of age-related macular degeneration progression using genetic risk scores, Genetics, 206, 119
- Seddon, 2015, Risk prediction for progression of macular degeneration: 10 common and rare genetic variants, demographic, environmental, and macular covariates, Invest. Ophthalmol. Vis. Sci, 56, 2192
- Perlee, 2013, Inclusion of genotype with fundus phenotype improves accuracy of predicting choroidal neovascularization and geographic atrophy, Ophthalmology, 120, 1880
- Huang da, 2009, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, Nat. Protoc, 4, 44
- Lambert, 2014, Gene expression pattern of cells from inflamed and normal areas of osteoarthritis synovial membrane, Arthritis Rheum, 66, 960
- Hollborn, 2007, Positive feedback regulation between MMP-9 and VEGF in human RPE cells, Invest. Ophthalmol Vis. Sci, 48, 4360
- Joachim, 2017, Five-year progression of unilateral age-related macular degeneration to bilateral involvement: the Three Continent AMD Consortium report, Br. J. Ophthalmol, 101, 1185
- Sardell, 2016, Progression rate from intermediate to advanced age-related macular degeneration is correlated with the number of risk alleles at the CFH locus, Invest. Ophthalmol. Vis. Sci, 57, 6107
- Davis, 2005, The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17, Arch. Ophthalmol, 123, 1484
- Zhang, 2002, Cox proportional hazards regression models for survival data in cancer research, Cancer. Treat. Res, 113, 59
- Lee, 1992, Survival Analysis, State of the Art, 237
Cited by
Sorted by citations
Lizama, B. N., Kahle, J., Catalano, S. M., Caggiano, A. O., Grundman, M., & Hamby, M. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076251 · Cited by 54
Metadata
- Authors
- Yan, Q., Ding, Y., Liu, Y., Sun, T., Fritsche, L. G., Clemons, T., Ratnapriya, R., Klein, M. L., Cook, R. J., Liu, Y., Fan, R., Wei, L., Abecasis, G. R., Swaroop, A., Chew, E. Y., AREDS2 Research Group, Weeks, D. E., & Chen, W.
- Affiliations
- Division of Pulmonary Medicine, Allergy and Immunology, Department of Pediatrics, Children’s Hospital of Pittsburgh of UPMC University of Pittsburgh, Pittsburgh, PA 15224, USA,
- Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA
- Center for Statistical Genetics, Department of Biostatistics, University of Michigan, Ann Arbor, MI 48109, USA
- The Emmes Corporation, Rockville, MD 20850, USA
- Neurobiology Neurodegeneration and Repair Laboratory, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
- Casey Eye Institute, Oregon Health & Science University, Portland, OR 97239, USA
- Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, ON N2L 3G1, Canada
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong Province 510030, China
- Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University Medical Center, Washington, DC 20007, USA
- Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
- ORCID
- Chen, Wei
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-01-15
- Volume
- 27
- Issue
- 5
- Pages
- 929-940
- ISSN
- 0964-6906
- 1460-2083
- Cited by
- 98
- References
- 4
- Language
- en
- Funders
- National Institutes of Health (EY024226, EY022005, EY021532)
- National Eye Institute (EY000474, EY000546)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
